RFICs
PRODUCTS
-
The SSV-h Checkweigher is a great cost-effective solution for industrial, pharmaceutical, and packaged food products that need to meet stringent accuracy and reliability standards. It is equipped with a force balance load cell that produces faster response and readings with maximum accuracy of +/- 0.01 g. The Smart Measurement Function uses improved signal processing, filtering, and scale resolution to reduce rejections due to double product errors. The giveaway feature calculates product excess both as total weight and percentage, allowing you to adjust filling levels and reduce costs. The SSV-h series comes with an IP30 dustproof rating that makes it ideal for non-washdown applications. Its lightweight and rigid conveyor can be easily disassembled and wiped clean without any tools.
-
CS, MS, VI: Our basic platforms for automatic high-speed inspection of vials, ampules, cartridges, and syringes
All three standard machines inspect up to 600 containers/minute, in addition to vials, ampules, cartridges, and syringes with liquid contents, as well as vials with lyo product. Depending on the inspection requirements, we can integrate any inspection technology of our Seidenader Solutions and add a machine module for leak testing.
-
Setting a New Benchmark for Ease of Operation
The NP-255 is a robust tablet press that was built to meet even the most demanding needs of the mid-sized tableting industry. The press has features and options designed to increase production, improve tablet quality, reduce waste, and set a new benchmark for ease of operation. Designed, engineered, and manufactured in the USA, this unique machine has a maximum production speed of 192,000 tablets per hour.
With a hardened steel die table, a gravity feeder that is interchangeable with a two-paddle forced feeder, and our industry-leading intuitive Natoli AIM™ ProPluscontrol system, the NP-255 is the new standard for value in the mid-sized tableting industry.
-
At Mikart, our mission is to leverage our technical expertise in pharmaceutical development and manufacturing to deliver services that meet the diverse needs of our customers.
-
Access specialized data and expertise to help navigate all stages of product development and support your success in oncology.
WHITE PAPERS AND CASE STUDIES
-
Achieving Complete Destruction Of PFAS Using electraCLEAR Process
In early 2023, Lacks Enterprises Inc., a large automotive component supplier in the midwestern US, engaged Axine to address destruction of legacy PFAS compounds in wastewater from its manufacturing processes.
-
Changing The Clinical Feasibility Game With AI
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
-
Expanding Accessibility In A Phase 3 Influenza Study Through Community-Based Research
By meeting participants where they are, this study sets a new benchmark for inclusive, efficient, and impactful vaccine development.
-
Streamlined Facility Design: A Success Story
Examine how one medium-sized US company's need for a new aseptic compounding and fill-finish facility was addressed with a tailored solution within a challenging time-frame.
-
Improving Patient Health And Safety: SOPs And Process Mapping
In this study, a biotech company faced compliance challenges due to inadequate SOPs that lacked detailed process maps. Propharma stepped in to provide a strategy and project plan.
-
Optimizing Early-Stage Oncology
A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.
-
EHR-To-EDC Success In A Complex, Adaptive Platform Trial
I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.
-
A Translational Mouse Model For Non-Genetic Heterotopic Ossification
Reproducing the thermal lesion/tenotomy-induced mouse model can help overcome the challenge of unpredictable heterotopic ossification localization and enable the development of targeted interventions.
-
Enhancing Municipal Water Storage With Submersible Mixers: A Case Study
Ice accumulation in water tanks poses serious challenges, compromising operations by trapping volumes of water and potentially costing tens of thousands of dollars in infrastructure damage. PAX Mixers are highly effective in preventing ice formation, even in extreme cold conditions. By optimizing water circulation, we can maintain consistent water temperatures within a tank.
-
Disinfection For Purified Water Loop For Kamada Pharmaceuticals, Israel
An Atlantium HOD™ (Hydro-Optic Disinfection) UV system was installed at the outlet of a PW tank to serve as the primary disinfection barrier, with water circulating through the system at 6m³/hr before reaching the points of use.
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
End-To-End Support To Advance Gene Therapies For Rare Retinal Diseases
Learn how expert analytical testing and clinical support helped advance a promising gene therapy for rare retinal diseases from the lab to the clinic on an expedited timeline.
NEWS
-
Ovarro Opens New Asia Pacific Headquarters8/27/2025
Water technology provider Ovarro has opened a new Asia Pacific headquarters and production facility in Selangor, Malaysia.
-
Canada Accelerates Transition To Zero-Emissions Vehicles8/13/2025
Canada is leading the way on the infrastructure, innovation and partnerships required to transition to electric transportation.
-
ZEISS Introduces The New Smartzoom 100: The Future Of Digital Microscopy For Efficient Optical Inspections5/6/2025
ZEISS presents the new ZEISS Smartzoom 100, an innovative digital microscope for fast and efficient quality assurance.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
Vodafone Reduces Its Advertising And Media Carbon Footprint By A Third1/7/2025
Vodafone has reduced the carbon footprint of its media and advertising activities by more than a third in a year across thirteen markets in total after benchmarking its media-related greenhouse gas (‘GHG') emissions and introducing global guidelines to mitigate them.
ABOUT
About Nutrient Removal
Nutrient removal from wastewater consists of treating wastewater to remove nitrogen and phosphorus before it reenters natural waterways. High levels of nitrogen and phosphorus in wastewater cause eutrophication, a process where excess nutrients stimulate excessive plant growth such as algal blooms and cyanobacteria. The decomposition of the algae by bacteria uses up the oxygen in the water causing other organisms to die. This creates more organic matter for the bacteria to decompose. In addition, some algal blooms can produce toxins that contaminate drinking water supplies.
As authorized by the Clean Water Act, the National Pollutant Discharge Elimination System (NPDES) permit program regulates point sources, such as municipal wastewater treatment plants, that discharge pollutants as effluent into the waters of the United States. In recent years, many of the States’ environmental bodies have lowered nutrient limits to arrest eutrophication. Maryland’s effort to protect the Chesapeake Bay and its tidal tributaries is perhaps the most notable example of nutrient removal in the US. Nutrient removal continues to be a growing area of focus for wastewater treatment throughout the world.
The removal of nitrogen and phosphorus require different nutrient removal processes. To remove nitrogen, the nitrogen is oxidized from ammonia to become nitrate through a process called nitrification. This process is then followed by denitrification where the nitrate is reduced to nitrogen gas which is released to the atmosphere and removed from the wastewater.
Nitrification is a two-step aerobic process which typically takes place in aeration tanks. Denitrification requires anoxic conditions to encourage the appropriate biological conditions to form. The activated sludge process is often used to reduce nitrate to nitrogen gas in anoxic or denitrification tanks.
Phosphorus can be removed biologically using polyphosphate accumulating organisms (PAOs) which accumulate large quantities of phosphorus within their cells and separate it from treated water. Phosphorus removal can also be achieved by chemical removal. Once removed as sludge, phosphorus may be stored in a land fill. However, many municipalities and treatment facilities are looking to resell the biosolids for use in fertilizer.